Cargando…
Exclusion of Older Adults in COVID-19 Clinical Trials
Autores principales: | Abi Jaoude, Joseph, Kouzy, Ramez, El Alam, Molly B., Subbiah, Vivek, Taniguchi, Cullen M., Ludmir, Ethan B., Lin, Timothy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427627/ https://www.ncbi.nlm.nih.gov/pubmed/33012364 http://dx.doi.org/10.1016/j.mayocp.2020.08.018 |
Ejemplares similares
-
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Cancer Research after COVID-19: Where Do We Go from Here?
por: Colbert, Lauren E., et al.
Publicado: (2020) -
Applying to Radiation Oncology Amid a Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020) -
Food and Drug Administration approvals in phase 3 Cancer clinical trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)